Forbion Growth Management B.V.

Forbion Growth Management B.V. is 10% Owner at NewAmsterdam Pharma Co N.V. (NAMS). They have made 1 open-market trade across 1 company since 2024, most recently 2024-12-11.

CIK 0001918318

Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.